MB
The startup specializes in mitochondrial transfusion therapy to combat age-related diseases such as Alzheimer's and Parkinson's. By enhancing mitochondrial function, the company aims to improve healing processes and reduce frailty in elderly patients and wounded soldiers.
Updated 3 months ago
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Features
- The startup specializes in mitochondrial transfusion therapy to combat age-related diseases such as Alzheimer's and Parkinson's. By enhancing mitochondrial function, the company aims to improve healing processes and reduce frailty in elderly patients and wounded soldiers.